The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy

Published:2016-04 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Peng Hao,Chen Lei,Li Wen-Fei,Guo Rui,Mao Yan-Ping,Zhang Yuan,Zhang Fan,Liu Li-Zhi,Tian Li,Lin Ai-Hua,Sun Ying,Ma Jun

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep24332.pdf

Reference28 articles.

1. Jemal, A., Bray, F. & Center, M. M. Global cancer statistics. CA Cancer J Clin. 61, 69–90 (2011).

2. Lee, A. W., Ng, W. T. & Chan, L. K. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral Oncol. 48, 1007–13 (2012).

3. Al-Sarraf, M., LeBlanc, M. & Giri, P. G. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 16, 1310–7 (1998).

4. Chan, A. T., Leung, S. F. & Ngan, R. K. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 97, 536–9 (2005).

5. Lee, A. W., Lau, W. H. & Tung, S. Y. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 23, 6966–75 (2005).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comments on “Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study”;Radiotherapy and Oncology;2024-08

2. Comparing the role of different treatment modalities in locoregionally advanced olfactory neuroblastoma: The 20‐year clinical experience of a single institution;Head & Neck;2023-06-12

3. Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort;Journal of Chemotherapy;2023-05-21

4. Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning;Journal of Otolaryngology - Head & Neck Surgery;2023-01

5. Survival effect of pretreatment FDG-PET–CT on nasopharyngeal cancer;Journal of the Formosan Medical Association;2023-01